SKI Market

Indian Indices

Sensex

83,739.13 2,072.67
( 2.54%)

Global Indices

Nasdaq

49,433.27 519.79
(1.06%)

Dow Jones

6,997.90 37.87
(0.54%)

Hang Seng

54,706.11 2,050.93
(3.90%)

Nikkei 225

10,322.91 99.37
(0.97%)

Forex

USD-INR

91.61 -0.04
(-0.05%)

EUR-INR

108.55 -0.05
(-0.05%)

GBP-INR

125.35 -0.06
(-0.05%)

JPY-INR

0.59 0.00
(-0.07%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Marksans Pharma Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

524404

INE750C01026

32.9918134

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

MARKSANS

30.89

7447.75

EPS(TTM)

Face Value()

Div & Yield %

5.32

0.49

Back

Quest Capital Markets standalone net profit declines 28.30% in the September 2025 quarter

Nov 11,2025

Net profit of Quest Capital Markets declined 28.30% to Rs 0.76 crore in the quarter ended September 2025 as against Rs 1.06 crore during the previous quarter ended September 2024. Sales declined 24.68% to Rs 1.16 crore in the quarter ended September 2025 as against Rs 1.54 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	1.16	1.54	-25
OPM %	87.93	91.56	-
PBDT	1.02	1.41	-28
PBT	1.02	1.41	-28
NP	0.76	1.06	-28

83,739.13 2,072.67 ( 2.54%)

49,433.27 519.79 (1.06%)

6,997.90 37.87 (0.54%)

54,706.11 2,050.93 (3.90%)

10,322.91 99.37 (0.97%)

91.61 -0.04 (-0.05%)

108.55 -0.05 (-0.05%)

125.35 -0.06 (-0.05%)

0.59 0.00 (-0.07%)